Sichuan Biokin Pharmaceutical Co.,Ltd. (SHA:688506)
China flag China · Delayed Price · Currency is CNY
266.84
-3.99 (-1.47%)
At close: Aug 31, 2026

SHA:688506 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
3,4355,1773,220403.961,005154.22
Short-Term Investments
3,9482,5042,533---
Trading Asset Securities
1,5912,159----
Cash & Short-Term Investments
8,9749,8405,753403.961,005154.22
Cash Growth
62.90%71.04%1324.16%-59.79%551.49%-36.99%
Accounts Receivable
80.32100.35138.71137.85267.92134.95
Other Receivables
18.3919.434.333.95.142.95
Receivables
98.71119.75173.05141.75273.06137.9
Inventory
164.88146.31162.19140.91101.3382.33
Other Current Assets
585.92384.42218.8789.247.2249.36
Total Current Assets
9,82310,4916,307775.821,426423.81
Property, Plant & Equipment
969.75816.31573.09534.79420.26404.98
Other Intangible Assets
29.5330.326.682829.5331.16
Long-Term Deferred Tax Assets
97.4538.21179.276.1883.2365.8
Long-Term Deferred Charges
26.7930.4618.41.821.791.16
Other Long-Term Assets
110.7641.7932.798.530.2824.54
Total Assets
11,05811,4487,1371,4251,991951.46

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
214.52206.83219.25160.17128.8545.96
Accrued Expenses
723.94621.31437.25257.88244.81139.81
Short-Term Debt
-100.08595.5275.12155.13161.23
Current Portion of Long-Term Debt
1,244841.49235.28174.3730.470.02
Current Portion of Leases
31.0523.912.4646.1368.8224.23
Current Income Taxes Payable
--14.130.014.961.54
Current Unearned Revenue
6.317.31356.138.6717.4210.78
Other Current Liabilities
103.17137.74109.94131.4886.7487.75
Total Current Liabilities
2,3231,9391,9801,054737.2471.32
Long-Term Debt
3,8142,6161,189183.92239.9650
Long-Term Leases
156.46132.828.138.6552.9551.42
Long-Term Unearned Revenue
122125.8242.2715.6313.2931.04
Long-Term Deferred Tax Liabilities
22.974.321.94-0.08-
Other Long-Term Liabilities
7.917.589.7311.1914.0515.81
Total Liabilities
6,4474,8253,2511,2731,058619.61

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
412.87412.87401401401360.9
Additional Paid-In Capital
4,6804,659885.84858.69858.5514.17
Retained Earnings
-92.271,5452,599-1,109-328.45-45.98
Comprehensive Income & Other
-20.465.50.531.132.792.76
Total Common Equity
4,6106,6233,886151.87933.89331.85
Shareholders' Equity
4,6106,6233,886151.87933.89331.85
Total Liabilities & Equity
11,05811,4487,1371,4251,991951.46

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
5,2463,7142,061688.19547.33286.91
Net Cash (Debt)
3,7276,1263,692-284.23457.41-132.69
Net Cash Growth
55.84%65.91%----
Net Cash Per Share
9.1015.189.21-0.711.26-0.37
Filing Date Shares Outstanding
412.87412.87401401401360.9
Total Common Shares Outstanding
412.87412.87401401401360.9
Working Capital
7,5008,5524,327-278.01689.14-47.51
Book Value Per Share
11.1716.049.690.382.330.92
Tangible Book Value
4,5816,5923,859123.88904.36300.69
Tangible Book Value Per Share
11.1015.979.620.312.260.83
Buildings
312.48323.1325.3304.56302.23300.82
Machinery
757.69717.87640.12554.25439.83419.75
Construction In Progress
259.18115.835.5181.3767.2118.18